Clinical trial
Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
NCT00315497 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00315497 |
|---|---|
| Title | Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis |
| Official title | Longitudinal Protocol for Giant Cell Arteritis |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | Office of Rare Diseases (ORD) NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Rare Diseases Clinical Research Network |
| Status | Completed |
| Study type | Observational |
| Conditions | Temporal Arteritis |
| Enrollment | 426 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2019 |
| Completion | Dec 1, 2019 |
| First posted | Apr 18, 2006 |
| Last update posted | Jul 12, 2022 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: